ES2093445T3 - Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos. - Google Patents
Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.Info
- Publication number
- ES2093445T3 ES2093445T3 ES93916182T ES93916182T ES2093445T3 ES 2093445 T3 ES2093445 T3 ES 2093445T3 ES 93916182 T ES93916182 T ES 93916182T ES 93916182 T ES93916182 T ES 93916182T ES 2093445 T3 ES2093445 T3 ES 2093445T3
- Authority
- ES
- Spain
- Prior art keywords
- injection
- water solvent
- solvent
- analogs
- methylsulfinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002347 injection Methods 0.000 title abstract 7
- 239000007924 injection Substances 0.000 title abstract 7
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title 1
- 229960000381 omeprazole Drugs 0.000 title 1
- 239000002904 solvent Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 230000000767 anti-ulcer Effects 0.000 abstract 2
- 239000003125 aqueous solvent Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
UNA INYECCION QUE CONTIENE UN COMPUESTO DE 2-[(2PIRIDIL)METILSULFINIL]-BENCIMIDAZOL O UNA SAL DEL MISMO QUE TIENEN UNA ACTIVIDAD ANTIULCERAS Y UN SOLVENTE ACUOSO AL QUE SE AÑADE UN SOLVENTE NO ACUOSO, EN DONDE EL PH DE LA INYECCION NO ES INFERIOR A 9,5 Y NO ES SUPERIOR A 11,5 Y UN KIT DE INYECCION QUE CONTIENE LAS SIGUIENTES (A) Y (B), EN DONDE (A) Y (B) SE AJUSTAN DE TAL MODO QUE EL PH TRAS LA DISOLUCION DE (A) EN (B) SEA DE 9,5 A 11,5: (A): UN PRODUCTO LIOFILIZADO DE UNA SOLUCION ACUOSA ALCALINA DE UN COMPUESTO DE 2-[(2-PIRIDIL)METILSULFINIL]BENCIMIDAZOL O UNA SAL DEL MISMO QUE TIENEN UNA ACTIVIDAD ANTIULCERAS; (B): UN SOLVENTE ACUOSO AL QUE SE AÑADE UN SOLVENTE NO ACUOSO. CON LA INYECCION DE LA PRESENTE INVENCION NO ES NECESARIO REDUCIR EL PH PARA PREVENIR LA HEMOLISIS O IRRITACION LOCAL, NI AÑADIR UN SOLVENTE NO ACUOSO A UN SOLVENTE ACUOSO PARA LA DISOLUCION PARA PREVENIR LA DEGRADACION CONCOMITANTE DE LAS PROPIEDAD DE DISOLUCION. SEGUN ESTO, LA INYECCION DE LA PRESENTE INVENCION PUEDEASEGURAR UNA SOLUBILIDAD SUFICIENTE PARA LA FORMULACION DE UNA PREPARACION Y SEGURIDAD PARA EL CUERPO HUMANO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20120392 | 1992-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2093445T3 true ES2093445T3 (es) | 1996-12-16 |
Family
ID=16437061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93916182T Expired - Lifetime ES2093445T3 (es) | 1992-07-28 | 1993-07-15 | Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5589491A (es) |
| EP (1) | EP0652751B1 (es) |
| KR (1) | KR100258423B1 (es) |
| AT (1) | ATE144421T1 (es) |
| AU (1) | AU674015B2 (es) |
| CA (1) | CA2140347C (es) |
| CZ (1) | CZ284249B6 (es) |
| DE (1) | DE69305642T2 (es) |
| DK (1) | DK0652751T3 (es) |
| ES (1) | ES2093445T3 (es) |
| FI (1) | FI113338B (es) |
| GR (1) | GR3021937T3 (es) |
| HK (1) | HK52397A (es) |
| HU (1) | HU226778B1 (es) |
| NO (1) | NO304098B1 (es) |
| NZ (1) | NZ254237A (es) |
| RU (1) | RU2126252C1 (es) |
| SG (1) | SG52479A1 (es) |
| SK (1) | SK279554B6 (es) |
| WO (1) | WO1994002141A1 (es) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4324014C2 (de) * | 1993-07-17 | 1995-06-08 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung |
| US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| SE9903831D0 (sv) * | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
| EP1310252A4 (en) * | 2000-08-18 | 2009-06-10 | Takeda Pharmaceutical | INJECTIONS |
| WO2002026210A2 (en) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Proton pump inhibitor formulation |
| MY137726A (en) | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
| US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| KR100467100B1 (ko) * | 2002-03-20 | 2005-01-24 | 일양약품주식회사 | 2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법 |
| US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
| US20040006109A1 (en) * | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of non-enterically coated acid-labile drugs |
| US20040081671A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of non-enterically coated acid-labile drugs |
| US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
| US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| AR045258A1 (es) * | 2003-08-21 | 2005-10-19 | Altana Pharma Ag | Un producto farmaceutico para inyeccion |
| ATE466579T1 (de) * | 2003-11-05 | 2010-05-15 | Lyka Labs Ltd | Verfahren zur herstellung von benzimidazolen |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
| WO2007091276A2 (en) * | 2006-02-10 | 2007-08-16 | Rajasthan Antibiotic Limited | Novel crystal form of omeprazol sodium |
| CN104288175A (zh) * | 2014-09-17 | 2015-01-21 | 大生祥(武汉）中医投资管理有限公司 | 一种新的苯并咪唑类异构体制剂及其制备方法 |
| PT3386507T (pt) * | 2015-12-08 | 2023-09-11 | Luoda Pharma Ltd | Métodos e composições para tratar úlceras gástricas |
| CN105919953A (zh) * | 2016-06-27 | 2016-09-07 | 峨眉山通惠制药有限公司 | 一种注射用奥美拉唑钠组合物及其制作工艺 |
| GB2585628A (en) * | 2019-05-08 | 2021-01-20 | Alkaloid Ad | Pharmaceutical formulation |
| CN112807282A (zh) * | 2021-01-13 | 2021-05-18 | 海南葫芦娃药业集团股份有限公司 | 一种奥美拉唑钠冻干粉针剂及其制备方法 |
| JP2025532389A (ja) | 2022-10-04 | 2025-09-29 | ザビリュク，アルセニー | 大動脈弁の石灰化の抑制 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| DK399389A (da) * | 1988-08-18 | 1990-02-19 | Takeda Chemical Industries Ltd | Injicerbare oploesninger |
| DK0382489T3 (da) * | 1989-02-10 | 1995-01-16 | Takeda Chemical Industries Ltd | Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf |
| US5049674A (en) * | 1989-12-20 | 1991-09-17 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
-
1993
- 1993-07-15 DK DK93916182.4T patent/DK0652751T3/da active
- 1993-07-15 RU RU95104936A patent/RU2126252C1/ru not_active IP Right Cessation
- 1993-07-15 KR KR1019950700327A patent/KR100258423B1/ko not_active Expired - Fee Related
- 1993-07-15 DE DE69305642T patent/DE69305642T2/de not_active Expired - Fee Related
- 1993-07-15 ES ES93916182T patent/ES2093445T3/es not_active Expired - Lifetime
- 1993-07-15 AU AU45838/93A patent/AU674015B2/en not_active Ceased
- 1993-07-15 AT AT93916182T patent/ATE144421T1/de not_active IP Right Cessation
- 1993-07-15 WO PCT/JP1993/000998 patent/WO1994002141A1/en not_active Ceased
- 1993-07-15 SK SK100-95A patent/SK279554B6/sk not_active IP Right Cessation
- 1993-07-15 HU HU9500245A patent/HU226778B1/hu not_active IP Right Cessation
- 1993-07-15 CA CA002140347A patent/CA2140347C/en not_active Expired - Lifetime
- 1993-07-15 NZ NZ254237A patent/NZ254237A/en not_active IP Right Cessation
- 1993-07-15 EP EP93916182A patent/EP0652751B1/en not_active Expired - Lifetime
- 1993-07-15 SG SG1996005084A patent/SG52479A1/en unknown
- 1993-07-15 US US08/373,245 patent/US5589491A/en not_active Expired - Lifetime
- 1993-07-15 CZ CZ95217A patent/CZ284249B6/cs not_active IP Right Cessation
-
1995
- 1995-01-17 NO NO950178A patent/NO304098B1/no not_active IP Right Cessation
- 1995-01-27 FI FI950379A patent/FI113338B/fi active
-
1996
- 1996-12-06 GR GR960403351T patent/GR3021937T3/el unknown
-
1997
- 1997-04-24 HK HK52397A patent/HK52397A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100258423B1 (ko) | 2000-07-01 |
| AU674015B2 (en) | 1996-12-05 |
| SG52479A1 (en) | 1998-09-28 |
| HU9500245D0 (en) | 1995-03-28 |
| GR3021937T3 (en) | 1997-03-31 |
| FI950379L (fi) | 1995-01-27 |
| KR950702419A (ko) | 1995-07-29 |
| DE69305642D1 (de) | 1996-11-28 |
| AU4583893A (en) | 1994-02-14 |
| HUT71900A (en) | 1996-02-28 |
| ATE144421T1 (de) | 1996-11-15 |
| DE69305642T2 (de) | 1997-02-27 |
| CZ284249B6 (cs) | 1998-10-14 |
| NO304098B1 (no) | 1998-10-26 |
| SK279554B6 (sk) | 1998-12-02 |
| EP0652751A1 (en) | 1995-05-17 |
| SK10095A3 (en) | 1995-07-11 |
| CA2140347C (en) | 2001-03-27 |
| NO950178D0 (no) | 1995-01-17 |
| HU226778B1 (en) | 2009-10-28 |
| CA2140347A1 (en) | 1994-02-03 |
| NO950178L (no) | 1995-01-17 |
| EP0652751B1 (en) | 1996-10-23 |
| HK52397A (en) | 1997-05-02 |
| CZ21795A3 (en) | 1995-10-18 |
| FI113338B (fi) | 2004-04-15 |
| FI950379A0 (fi) | 1995-01-27 |
| DK0652751T3 (da) | 1996-11-18 |
| WO1994002141A1 (en) | 1994-02-03 |
| RU2126252C1 (ru) | 1999-02-20 |
| US5589491A (en) | 1996-12-31 |
| NZ254237A (en) | 1995-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2093445T3 (es) | Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos. | |
| ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
| MX162618A (es) | Articulo microbiocida con liberacion prolongada,para sistemas acuosos | |
| ATE287710T1 (de) | Verfahren zum modulieren der mikrozirkulation | |
| DK261490D0 (da) | New pharmaceutical compound | |
| GR3005398T3 (es) | ||
| BR0304298A (pt) | Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume | |
| ATE162081T1 (de) | Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen | |
| DK0666739T3 (da) | Intravenøs opløsning som formindsker protein- og vandtab fra kroppen | |
| NO912414D0 (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
| ATE226428T1 (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen | |
| PE108599A1 (es) | Procedimiento para la estabilizacion de acido ascorbico levogiro (laa), composicion acuosa estable de laa, procedimiento para la preparacion de una solucion topica estable de laa, emulsion y producto vitaminico que lo contiene | |
| FI971949A0 (fi) | Varastoinninkestävä, trombiini-inhibiittoria sisältävä vesiliuos infuusiota varten | |
| AR246958A1 (es) | Procedimiento para preparar 1-hidroximetilpirazol. | |
| NO923198L (no) | Terapeutiske midler | |
| ES2037758T3 (es) | Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion. | |
| ATE168004T1 (de) | Juckreizstillendes mittel | |
| JPS56156211A (en) | Preparation of stable allantoin pharmaceutical | |
| JPS57112367A (en) | Preparation of stable aqueous solution of compound having thiol group | |
| MX9302818A (es) | Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina. | |
| JPS5762218A (en) | Ophthalmic solution | |
| AR247095A1 (es) | Composicion limpida, acuosa, estable en estante, para el tenido del cabello humano. | |
| AR005724A1 (es) | Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple | |
| JPS6056683B2 (ja) | 安定化されたカルプロニウムクロライド配合剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 652751 Country of ref document: ES |